News Conference News ESC 2015 Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI Yael L. Maxwell August 31, 2015
News Conference News ESC 2015 Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients Caitlin E. Cox August 31, 2015
Presentation ESC 2015 CIRCUS Study: Does Cyclosporine Improve Clinical Outcome is ST-Elevation Myocardial Infarction Patients? Presenter: Michael Ovize August 30, 2015
Presentation ESC 2015 Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up Presenter: Gilles Montalescot August 30, 2015
News Conference News ESC 2015 Failed Trial PRomPTs Questions About Role of Peri-Infarct Pacing for Remodeling of Large MIs L.A. McKeown August 30, 2015
News Conference News ESC 2015 CIRCUS: Transplant Rejection Drug Fails to Reduce Infarct Size in Anterior STEMI L.A. McKeown August 30, 2015
News Conference News ESC 2015 BACC: Rapid Rule Out Protocol Safe for Acute MI Diagnosis Yael L. Maxwell August 30, 2015
News Conference News ESC 2015 ALBATROSS: Aldersterone Blockade Fails to Improve Outcomes in Acute MI Caitlin E. Cox August 30, 2015
News Conference News ESC 2014 ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall Todd Neale September 08, 2014
News Conference News ESC 2014 RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years Caitlin E. Cox September 03, 2014
News Conference News ESC 2014 ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients Yael L. Maxwell September 03, 2014
Presentation ESC 2014 Predictors of Bleeding in ACS Patients Treated With Prasugrel: Analysis From the ACCOAST Study Presenter: Petr Widimsky September 02, 2014
Presentation ESC 2014 10-year mortality outcome of a routine invasive strategy in non-ST segment elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial Presenter: Robert A. Henderson September 02, 2014
News Conference News ESC 2014 MITOCARE: Novel Drug as Adjunct to PCI for STEMI Does Not Reduce Reperfusion Injury Risk Yael L. Maxwell September 02, 2014
News Conference News ESC 2014 IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI Todd Neale September 02, 2014
News Conference News ESC 2014 FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years Caitlin E. Cox September 02, 2014
News Conference News ESC 2014 Another Strike Against Thrombectomy in 1-Year TASTE Results Todd Neale September 02, 2014
News Conference News ESC 2014 NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin Caitlin E. Cox September 01, 2014
News Conference News ESC 2014 FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI Todd Neale September 01, 2014